Rethinking triple-negative breast cancer treatment through EGFR co-targeting and nanotechnology
Triple-negative breast cancer (TNBC)remains one of the most challenging forms of breast cancer to treat because it lacks the estrogen, progesterone and HER2 receptors that enable targeted treatment in other breast cancer subtypes. A review…